Which AMD treatment will restore vision, Macugen, Visudyne or both?

Prepare for the Certified Paraoptometric Assistant (CPOA) Exam. Study with extensive flashcards and multiple choice questions with explanations. Enhance your skills and knowledge to succeed.

Multiple Choice

Which AMD treatment will restore vision, Macugen, Visudyne or both?

Explanation:
Both AMD treatments aim to slow or stabilize the disease rather than bring back lost central vision. Macugen, or pegaptanib, targets a specific VEGF to reduce the growth of abnormal vessels, which helps slow vision loss in neovascular AMD but does not restore vision you’ve already lost. Visudyne, used with photodynamic therapy, works by shutting down abnormal vessels to prevent further leakage and damage, helping preserve existing vision but not reversing damage to the macula. Because neither therapy repairs vision that has already been lost, the correct choice is that none of these options restore vision.

Both AMD treatments aim to slow or stabilize the disease rather than bring back lost central vision. Macugen, or pegaptanib, targets a specific VEGF to reduce the growth of abnormal vessels, which helps slow vision loss in neovascular AMD but does not restore vision you’ve already lost. Visudyne, used with photodynamic therapy, works by shutting down abnormal vessels to prevent further leakage and damage, helping preserve existing vision but not reversing damage to the macula. Because neither therapy repairs vision that has already been lost, the correct choice is that none of these options restore vision.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy